Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without AS03 Adjuvant (HIPC: VAX-010)
Phase of Trial: Phase II
Latest Information Update: 18 Feb 2019
Price : $35 *
At a glance
- Drugs AS03A (Primary) ; Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Pharmacodynamics
- 18 Feb 2019 Last checked against the ClinicalTrials.gov record.
- 27 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Dec 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 May 2015 to 1 Feb 2015.